Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902)
- Citation:
- J Clin Oncol vol 32 (5s) (suppl); abstr 2030
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2578
- Pharmas:
- Grants:
- Corr. Author:
- Evanthia Galanis
- Authors:
- Evanthia Galanis S. Keith Anderson C. Ryan Miller Jann Nagina Sarkaria Kurt A. Jaeckle Jan C. Buckner Keith L. Ligon Karla V. Ballman Dennis Frederic Moore Manmeet Singh Ahluwalia Eudocia Quant Lee Elizabeth Robins Gerstner Glenn Jay Lesser Michael Prados Stuart A. Grossman Caterina Giannini Patrick Y. Wen
- Networks:
- Study
- NCCTG-N0874
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: